gliclazide has been researched along with Cochlear Hearing Loss in 1 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We evaluated insulin resistance and assessed the effect of gliclazide on insulin resistance in a patient with diabetes mellitus associated with Turner's syndrome." | 3.69 | Insulin resistance in a patient with diabetes mellitus associated with Turner's syndrome. ( Hashimoto, K; Hisatake, K; Kumon, Y; Suehiro, T; Sumiyoshi, R, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumon, Y | 1 |
| Hisatake, K | 1 |
| Suehiro, T | 1 |
| Sumiyoshi, R | 1 |
| Hashimoto, K | 1 |
1 other study available for gliclazide and Cochlear Hearing Loss
| Article | Year |
|---|---|
Insulin resistance in a patient with diabetes mellitus associated with Turner's syndrome.
Topics: Adult; Diabetes Complications; Diabetes Mellitus; Female; Gliclazide; Glucose Clamp Technique; Gluco | 1994 |